Scott B. Ullem
At a glance: Scott B. Ullem is CFO at Edwards Lifesciences (EW). Their latest SEC Form 4, filed Apr 9, 2026, reported a sale of $376K. On file: 0 purchase lines ($0) and 7 sale lines ($3.9M).
Disclosed holdings: about $4.1M of EW stock: 39,699 shares reported on their latest Form 4 (filed Apr 9, 2026), valued at the Nov 19, 2026 close of $103.72. This counts only EW shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Scott B. Ullem's InsiderPrint
7 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 7 times a year, typically $650K a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (0)
- Dent inward: a sale (7)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Michael MassaroCEO · FLYW · 100% match
- Jeffrey LiawCEO · CPRT · 100% match
- Paul ScannellPresident · CDNS · 100% match
- Timothy J. DonahueCEO, President · CCK · 100% match
- Terrance P. CoyneCFO · RPRX · 100% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 9SEC | EWEdwards Lifesciences Corp | Sell Plan | 4,67648,023 held (−9%) | $80.50 | $376K | +28.9% |
| Apr 9SEC | EWEdwards Lifesciences Corp | Sell Plan | 8,32439,699 held (−17%) | $79.79 | $664K | +30.0% |
| Mar 11SEC | EWEdwards Lifesciences Corp | Sell Plan | 5,09947,600 held (−10%) | $84.46 | $431K | +22.8% |
| Mar 11SEC | EWEdwards Lifesciences Corp | Sell Plan | 7,90139,699 held (−17%) | $85.21 | $673K | +21.7% |
| Dec 9SEC | EWEdwards Lifesciences Corp | Sell Plan | 7,70039,898 held (−16%) | $84.47 | $650K | +22.8% |
| Nov 10SEC | EWEdwards Lifesciences Corp | Sell Plan | 2,97449,924 held (−6%) | $83.30 | $248K | +24.5% |
| Nov 10SEC | EWEdwards Lifesciences Corp | Sell Plan | 10,02639,898 held (−20%) | $83.02 | $832K | +24.9% |
- Sell
CFO Scott B. Ullem sold $376K of EW at $80.50 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Scott B. Ullem sold $664K of EW at $79.79 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Scott B. Ullem sold $431K of EW at $84.46 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Scott B. Ullem sold $673K of EW at $85.21 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Scott B. Ullem sold $650K of EW at $84.47 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Scott B. Ullem sold $248K of EW at $83.30 — pre-scheduled 10b5-1 plan sale.
Follow Scott B. Ullem
Get one email when Scott B. Ullem files a new purchase or sale. Free.
At most one email a day about Scott B. Ullem, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.